Editorial: understanding sex and gender dimorphism in chronic diseases may improve outcomes
- PMID: 31414536
- DOI: 10.1111/apt.15421
Editorial: understanding sex and gender dimorphism in chronic diseases may improve outcomes
Comment on
-
Earlier discontinuation of TNF-α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects.Aliment Pharmacol Ther. 2019 Aug;50(4):386-396. doi: 10.1111/apt.15380. Epub 2019 Jul 16. Aliment Pharmacol Ther. 2019. PMID: 31310690
References
REFERENCES
-
- Hankivsky O, Springer KW, Hunting G. Beyond sex and gender difference in funding and reporting of health research. Res Integr Peer Rev. 2018;3:6.
-
- Shi HY, Levy AN, Trivedi HD, Chan F, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol. 2018;16:190-197.e11.
-
- van der Giessen J, Huang VW, van der Woude CJ, Fuhler GM. Modulatory effects of pregnancy on inflammatory bowel disease. Clin Transl Gastroenterol. 2019;10:e00009.
-
- Ordas I, Mould DR, Feagan BG. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther. 2012;91:635-646.
-
- Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel disease - pooled analysis of population-based studies from Western countries. Gastroenterology. 2018;155:1079-1089.e3.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources